Joe Renny, Head of Corporate Development at CatSci, returns to Trailblazers to explore whether a new Cold War is emerging around pharmaceutical innovation. He and Perry Rearick discuss China’s growing role in drug discovery, the push for scientific and supply chain sovereignty, the future of IP and patent protection, and how AI could increase productivity without replacing the human expertise needed to turn science into medicines.
B2B: Baseball To Business With Bob File
Bob File joins the Trailblazers to discuss technology, digital transformation & AI, and how life sciences and clinical trials are being impacted. He reminds us that human beings in the loop are the most important feature of AI. Bob is also a former Major League...



